NAFLD Clinical Care Pathway for Veterans
This study is testing a new approach called the NAFLD Clinical Care Pathway (NCCP) to improve how non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are diagnosed and managed in Veterans. NAFLD is a common liver condition, especially for Veterans with obesity and diabetes. The NCCP intervention uses an "e-trigger" to automatically identify patients at risk, calculates a risk score (FIB-4), and then educates healthcare teams on how to care for these patients. The goal is to ensure more Veterans with NAFLD are diagnosed and receive appropriate care. We are looking for Patient Aligned Care Teams (PACT) at the Michael E. DeBakey VA Medical Center to participate. The study will measure how well NAFLD is diagnosed and risk-stratified at the start and after 6 months.
- Study design
- This is an interventional study involving 32 Patient Aligned Care Teams (PACTs). The study aims to improve the diagnosis and risk assessment of NAFLD.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be assessed at the start of the study and again after 6 months for NAFLD diagnosis and risk stratification.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
NAFLD Clinical Care Pathway
At a glance
Conditions
NCT06671886
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Hashem B. El-Serag, MD MPH · PRINCIPAL_INVESTIGATOR · Michael E. DeBakey VA Medical Center, Houston, TX
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Exclusion
What this trial measures
- NAFLD Diagnosis and risk stratificationBaseline, 6 months
The investigators will use chart reviews to extract unstructured data regarding the primary outcome measure: existence of EHR progress note documenting a new NAFLD diagnosis AND complete risk stratification of NAFLD (i.e., fibrosis). The investigators will use our validated process to guide uniform abstraction and classification.